Huaren Pharmaceutical Co., Ltd.
Huaren Pharmaceutical Co., Ltd., headquartered in China, is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of high-quality medicinal products. Founded in 2001, the company has established a strong presence in both domestic and international markets, focusing on innovative solutions in areas such as oncology, cardiology, and infectious diseases. With a commitment to excellence, Huaren Pharmaceutical offers a diverse portfolio of core products, including generic medications and proprietary formulations that stand out for their efficacy and safety. The company has achieved significant milestones, including various certifications and partnerships that enhance its market position. Recognised for its dedication to quality and innovation, Huaren Pharmaceutical continues to contribute to global health advancements while maintaining a strong reputation in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Huaren Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huaren Pharmaceutical Co., Ltd.'s score of 21 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Huaren Pharmaceutical Co., Ltd.'s reported carbon emissions
In 2023, Huaren Pharmaceutical Co., Ltd., headquartered in China, reported emissions data indicating a waste gas emission intensity of approximately 6.69 kg CO2e per unit of revenue. This figure reflects the company's operational impact but does not specify total emissions across Scope 1, 2, or 3, as no detailed emissions data has been disclosed for these scopes. In 2022, the company recorded a similar waste gas emission intensity of about 6.58 kg CO2e per unit of revenue. Despite these figures, Huaren Pharmaceutical has not established any formal reduction targets or climate pledges, indicating a potential area for improvement in their sustainability strategy. Overall, while Huaren Pharmaceutical is actively monitoring its emissions intensity, the absence of comprehensive emissions data and reduction commitments suggests that the company may need to enhance its climate action initiatives to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Huaren Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
